Vanguard Capital Management
ABBV icon

Vanguard Capital Management’s AbbVie ABBV Stock Holding History

Vanguard Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.3B Buy
115,676,728
+280,630
+0.2% +$71.9M 0.64% 19
2026
Q2 		$29B Buy
115,396,098
+515,774
+0.4% +$111M 0.62% 23
2026
Q1 		$25B Buy
+114,880,324
New +$25.5B 0.62% 21

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vanguard Capital Management's ABBV Position: Q3 2026 in Review

Vanguard Capital Management increased its AbbVie (ABBV) stake by 0.24% in Q3 2026, buying an estimated $71.9M and bringing the position to 115,676,728 shares worth $30.3B. The position accounts for 0.64% of the portfolio, ranked #19.

Vanguard Capital Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Vanguard Capital Management held 115,676,728 shares of AbbVie worth $30.3B as of Q3 2026.
  • Vanguard Capital Management bought 280,630 AbbVie shares in Q3 2026, an estimated $71.9M.
  • AbbVie made up 0.64% of Vanguard Capital Management's portfolio in Q3 2026, its #19 holding.
  • Vanguard Capital Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.